Clinical Trial Update: Study to Evaluate the Inflammatory Cells Activity in Patients With Persistent Asthma Treated With Montelukast (0476-403)(COMPLETED) [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the inflammatory cell activity in adults with persistent asthma treated with montelukast and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Montelukast (Singulair) (montelukast)

Snippet

Sponsor: University of Brasilia | Conditions: Asthma | Phase 4 | Status: COMPLETED